On November 2, 2018 Arix Bioscience plc (LSE: ARIX) ("Arix"), a global healthcare and life science company supporting medical innovation notes one of its Group Businesses, Autolus Therapeutics plc (NASDAQ: AUTL) (Autolus), reported that it will present one oral and two poster presentations related to its AUTO3 and AUTO5 programs at the 60th American Society of Hematology (ASH) (Free ASH Whitepaper) Annual Meeting and Exposition, to be held December 1-4, 2018 in San Diego, CA (Press release, Autolus, NOV 2, 2018, View Source [SID1234530693]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The announcement can be accessed on Autolus’ investor website at View Source and full text of the announcement from Autolus is contained below